Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson pushes back to 2012 the target for returning its full slate of recalled OTC drugs to market as it adjusts to operating under a consent decree with FDA and the Department of Justice.